Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series

IMPORTANCE: In response to the coronavirus disease 2019 (COVID-19) pandemic, 2 mRNA vaccines (Pfizer-BioNTech and Moderna) received emergency use authorization from the US Food and Drug Administration in December 2020. Some patients in the US have developed delayed localized cutaneous vaccine reacti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of dermatology (1960) 2021-06, Vol.157 (6), p.716-720
Hauptverfasser:	Johnston, Margaret S, Galan, Anjela, Watsky, Kalman L, Little, Alicia J
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Adult Aged Aged, 80 and over Brief Report Comments Connecticut - epidemiology COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects Drug Eruptions - diagnosis Drug Eruptions - drug therapy Drug Eruptions - epidemiology Drug Eruptions - immunology Female Histamine Antagonists - therapeutic use Humans Injection Site Reaction - diagnosis Injection Site Reaction - drug therapy Injection Site Reaction - epidemiology Injection Site Reaction - immunology Male Middle Aged Online First Retrospective Studies Side effects Skin - immunology Skin - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!